Total records found: 96
Hide HeadlineShow Headline
Sort
Release Time Stock Code Stock Short Name Document
Release Time: 03/07/2026 19:24 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2026 (68KB)
Release Time: 01/07/2026 19:09 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT Enrollment Completed in the Global Multicenter Registrational Phase III Clinical Trial of Tinengotinib Monotherapy for Patients with Advanced Cholangiocarcinoma (41KB)
Release Time: 01/07/2026 19:03 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT Approval Granted for Phase II Clinical Trial in China of TT-01488 Tablets in Combination with Anti-CD20 Monoclonal Antibody for the Treatment of Mantle Cell Lymphoma (41KB)
Release Time: 28/06/2026 18:02 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT INTENTION TO CONDUCT ON-MARKET SHARE REPURCHASE UNDER GENERAL MANDATE (40KB)
Release Time: 18/06/2026 20:50 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of Other Board Committees]
Terms of Reference of the Strategy Committee of the Board of Directors (26KB)
Release Time: 18/06/2026 20:46 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of the Remuneration Committee]
Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors (38KB)
Release Time: 18/06/2026 20:42 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of the Nomination Committee]
Terms of Reference of the Nomination Committee of the Board of Directors (38KB)
Release Time: 18/06/2026 20:38 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of the Audit Committee]
Terms of Reference of the Audit Committee of the Board of Directors (50KB)
Release Time: 18/06/2026 20:32 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Constitutional Documents
Articles of Association (193KB)
Release Time: 18/06/2026 20:28 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (45KB)
Release Time: 18/06/2026 20:24 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Results of AGM / Re-election or Appointment of Director subject to Shareholders' Approval /...
More
Announcements and Notices - [Results of AGM / Re-election or Appointment of Director subject to Shareholders' Approval / Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member / Change of Nomination Committee Member / Change in Supervisors / Amendment of Constitutional Documents]
]
(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 18 JUNE 2026; (2) CHANGE OF THE INDEPENDENT NON-EXECUTIVE DIRECTOR AND COMPOSITION OF BOARD COMMITTEES; (3) CANCELLATION OF THE SUPERVISORY COMMITTEE; AND (4) AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ITS APPENDICES (49KB)
Release Time: 18/06/2026 20:17 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Results of EGM/SGM / Share Scheme]
(1) POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 18 JUNE 2026; (2) ADOPTION OF THE H SHARE AWARD SCHEME; AND (3) AUTHORIZATION TO THE SCHEME ADMINISTRATOR TO DEAL WITH MATTERS RELATED TO THE H SHARE AWARD SCHEME (44KB)
Release Time: 12/06/2026 21:21 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT Appointment of Chief Operating Officer (45KB)
Release Time: 02/06/2026 18:37 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026 (69KB)
Release Time: 31/05/2026 18:04 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT TransThera Sciences (Nanjing), Inc. announces poster presentation for pivotal phase II trial clinical data of Tinengotinib monotherapy in pre-treated FGFR2-altered cholangiocarcinoma at 2026 ASCO (48KB)
Release Time: 27/05/2026 20:58 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (84KB)
Release Time: 27/05/2026 20:54 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
COMPLETION OF PLACING OF NEW H SHARES UNDER THE GENERAL MANDATE (84KB)
Release Time: 26/05/2026 22:59 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Proxy Forms
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON THURSDAY, 18 JUNE 2026 AT 10:30 A.M. (49KB)
Release Time: 26/05/2026 22:57 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (50KB)
Release Time: 26/05/2026 22:53 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director...
More
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval / Amendment of Constitutional Documents]
]
CIRCULAR OF ANNUAL GENERAL MEETING (378KB)
Release Time: 26/05/2026 21:37 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL APPROVAL OF TINENGOTINIB IN COMBINATION WITH NOVEL HORMONE THERAPY FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER PRIOR TREATMENTS IN CHINA (40KB)
Release Time: 26/05/2026 21:28 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT TransThera Sciences (Nanjing), Inc. and Shanghai Allist Pharmaceuticals Co., Ltd. Announce a Collaboration Agreement to Jointly Evaluate the Combination of TT-00973-MS Tablets with Firmonertinib Mesylate Tablets in the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR-Sensitive Mutations (46KB)
Release Time: 22/05/2026 22:55 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Documents on Display
RULES RELATING TO THE 2026 H SHARE AWARD SCHEME (143KB)
Release Time: 22/05/2026 22:54 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Proxy Forms
FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING TO BE HELD ON 18 JUNE 2026 OR ANY ADJOURNMENT THEREOF (65KB)
Release Time: 22/05/2026 22:51 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Notice of EGM/SGM / Closure of Books or Change of Book Closure Period]
NOTICE OF THE EXTRAORDINARY GENERAL MEETING (62KB)
Release Time: 22/05/2026 22:50 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Circulars - [Share Scheme / Other]
(1) PROPOSED ADOPTION OF THE H SHARE AWARD SCHEME (2) PROPOSED AUTHORIZATION TO THE SCHEME ADMINISTRATOR TO DEAL WITH MATTERS RELATED TO THE H SHARE AWARD SCHEME AND (3) NOTICE OF THE EGM (244KB)
Release Time: 19/05/2026 06:30 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
PLACING OF NEW H SHARES UNDER GENERAL MANDATE (117KB)
Release Time: 17/05/2026 18:37 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT TransThera Sciences (Nanjing) Publishes Clinical Results of Tinengotinib as Monotherapy and in Combination with Atezolizumab for Advanced Solid Tumors on Nature Communications (38KB)
Release Time: 06/05/2026 19:23 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 (Re-submission) (69KB)
Release Time: 06/05/2026 15:49 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2026 (69KB)
Release Time: 23/04/2026 22:35 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Financial Statements/ESG Information - [Environmental, Social and Governance Information/Report]
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2025 (19MB)
Release Time: 23/04/2026 22:30 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Financial Statements/ESG Information - [Annual Report]
ANNUAL REPORT 2025 (2MB)
Release Time: 21/04/2026 19:05 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (84KB)
Release Time: 21/04/2026 19:00 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
COMPLETION OF PLACING OF NEW H SHARES UNDER THE GENERAL MANDATE (85KB)
Release Time: 21/04/2026 08:00 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT TransThera Sciences (Nanjing), Inc. Presented Lineage Reprogramming as a Resistance Mechanism to Endocrine Therapy in HR+ Breast Cancer, as Well as Preclinical Data for Tiangotinib at the 2026 American Association for Cancer Research (AACR) Annual Meeting (62KB)
Release Time: 17/04/2026 18:39 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN CONFIRMATORY PHASE III CLINICAL TRIAL OF TINENGOTINIB MONOTHERAPY FOR THE TREATMENT OF PATIENTS WITH ADVANCED CHOLANGIOCARCINOMA (41KB)
Release Time: 15/04/2026 06:30 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
PLACING OF NEW H SHARES UNDER GENERAL MANDATE (114KB)
Release Time: 07/04/2026 19:39 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Share Scheme]
PROPOSED ADOPTION OF THE H SHARE AWARD SCHEME (50KB)
Release Time: 02/04/2026 15:41 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2026 (68KB)
Release Time: 31/03/2026 19:55 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (45KB)
Release Time: 31/03/2026 19:50 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Re-election or Appointment of Director subject to Shareholders' Approval / Change in...
More
Announcements and Notices - [Re-election or Appointment of Director subject to Shareholders' Approval / Change in Directors or of Important Executive Functions or Responsibilities / Change of Audit Committee Member / Change of Remuneration Committee Member / Change of Nomination Committee Member]
]
CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND RESIGNATION OF NON-EXECUTIVE DIRECTOR (53KB)
Release Time: 31/03/2026 19:43 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Amendment of Constitutional Documents / Other - Corporate Governance Related Matters]
DISSOLUTION OF THE SUPERVISORY COMMITTEE AND PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION, THE RULES OF PROCEDURE OF SHAREHOLDERS' GENERAL MEETINGS AND THE RULES OF PROCEDURE OF THE BOARD OF DIRECTORS (44KB)
Release Time: 31/03/2026 18:40 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Final Results / Closure of Books or Change of Book Closure Period]
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025 (198KB)
Release Time: 19/03/2026 18:09 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (35KB)
Release Time: 18/03/2026 18:51 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF TINENGOTINIB IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF PREVIOUSLY TREATED HR+/HER2 - RELAPSED OR METASTATIC BREAST CANCER (40KB)
Release Time: 09/03/2026 18:40 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS A CONSTITUENT OF THE HANG SENG INDEX SERIES (40KB)
Release Time: 03/03/2026 18:30 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2026 (68KB)
Release Time: 04/02/2026 14:10 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2026 (69KB)
Release Time: 20/01/2026 17:06 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Next Day Disclosure Returns - [Others]
Next Day Disclosure Return (84KB)
Release Time: 20/01/2026 16:55 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
COMPLETION OF PLACING OF NEW H SHARES UNDER THE GENERAL MANDATE (87KB)
Release Time: 14/01/2026 06:30 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Placing / Issue of Shares under a General Mandate]
PLACING OF NEW H SHARES UNDER GENERAL MANDATE (113KB)
Release Time: 12/01/2026 07:00 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PRESENTATION OF CLINICAL DATA ANALYSIS OF TINENGOTINIB MONOTHERAPY IN PATIENTS WITH ADVANCED CHOLANGIOCARCINOMA AT 2026 ASCO GI (40KB)
Release Time: 05/01/2026 14:27 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2025 (65KB)
Release Time: 19/12/2025 08:11 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION FOR TINENGOTINIB TABLETS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION (42KB)
Release Time: 18/12/2025 12:01 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
(Headlines Revised) Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT PUBLICATION OF CLINICAL RESULTS OF OUR CORE PRODUCT TINENGOTINIB AGAINST CHOLANGIOCARCINOMA (39KB)
Release Time: 17/12/2025 19:54 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
(Cancelled since Headlines Superseded and Replaced) Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT PUBLICATION OF CLINICAL RESULTS OF OUR CORE PRODUCT TINENGOTINIB AGAINST CHOLANGIOCARCINOMA (39KB)
Release Time: 03/12/2025 17:10 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT INCLUSION OF TINENGOTINIB TABLETS IN THE LIST OF PRODUCTS FOR PRIORITY REVIEW BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION (40KB)
Release Time: 02/12/2025 15:27 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025 (65KB)
Release Time: 04/11/2025 14:00 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025 (65KB)
Release Time: 03/11/2025 08:03 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT COLLABORATION WITH NEUROCRINE (37KB)
Release Time: 20/10/2025 17:45 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Inside Information]
INSIDE INFORMATION ANNOUNCEMENT PROPOSED IMPLEMENTATION OF THE H SHARE FULL CIRCULATION BY THE COMPANY (49KB)
Release Time: 03/10/2025 15:21 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2025 (65KB)
Release Time: 19/09/2025 16:42 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Financial Statements/ESG Information - [Interim/Half-Year Report]
INTERIM REPORT 2025 (2MB)
Release Time: 16/09/2025 12:03 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS (37KB)
Release Time: 10/09/2025 21:46 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT PHASE II IND APPROVAL OF TINENGOTINIB IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF PREVIOUSLY TREATED HR+/HER2 NEGATIVE OR LOW EXPRESSION RELAPSED OR METASTATIC BREAST CANCER (41KB)
Release Time: 04/09/2025 22:32 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT FIRST PATIENT DOSED IN PHASE II CLINICAL TRIAL OF TINENGOTINIB IN COMBINATION WITH AKESO'S (CADONILIMAB, PD-1/CTLA-4) / (IVONESCIMAB, PD-1/VEGF) (44KB)
Release Time: 02/09/2025 15:36 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2025 (65KB)
Release Time: 25/08/2025 22:32 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
VOLUNTARY ANNOUNCEMENT INCLUSION OF THE COMPANY AS A CONSTITUENT OF THE HANG SENG INDEX SERIES (39KB)
Release Time: 25/08/2025 20:18 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Interim Results]
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 (206KB)
Release Time: 25/08/2025 20:11 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Change in Registered Address or Office, Registered Place of Business in HK or Agent for...
More
Announcements and Notices - [Change in Registered Address or Office, Registered Place of Business in HK or Agent for Service of Process in HK]
]
CHANGE OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG (229KB)
Release Time: 13/08/2025 17:11 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Date of Board Meeting]
DATE OF BOARD MEETING (35KB)
Release Time: 04/08/2025 18:36 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Results of AGM]
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 4 AUGUST 2025 (48KB)
Release Time: 04/08/2025 18:22 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2025 (65KB)
Release Time: 11/07/2025 21:41 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Proxy Forms
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON MONDAY, 4 AUGUST 2025 (74KB)
Release Time: 11/07/2025 21:39 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Notice of AGM / Closure of Books or Change of Book Closure Period]
NOTICE OF ANNUAL GENERAL MEETING (70KB)
Release Time: 11/07/2025 21:37 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director...
More
Circulars - [General Mandate / Explanatory Statement for Repurchase of Shares / Re-election or Appointment of Director subject to Shareholders' Approval / Other]
]
CIRCULAR OF ANNUAL GENERAL MEETING (244KB)
Release Time: 10/07/2025 12:01 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
New Arrangements on Dissemination of Corporate Communications to Non-Registered Shareholders (444KB)
Release Time: 10/07/2025 12:01 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Miscellaneous]
New Arrangements on Dissemination of Corporate Communications to Registered Shareholders (220KB)
Release Time: 07/07/2025 14:55 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Monthly Returns
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2025 (66KB)
Release Time: 24/06/2025 06:07 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Other - Business Update]
VOLUNTARY ANNOUNCEMENT GRANT OF TINENGOTINIB (TT-00420) FAST TRACK DESIGNATION FOR TREATMENT OF MCRPC (40KB)
Release Time: 22/06/2025 18:39 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Allotment Results]
CLARIFICATION ANNOUNCEMENT (873KB)
Release Time: 20/06/2025 22:46 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Allotment Results]
ANNOUNCEMENT OF ALLOTMENT RESULTS (918KB)
Release Time: 20/06/2025 12:22 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [List of Directors and their Role and Function]
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS (418KB)
Release Time: 20/06/2025 12:19 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of Other Board Committees]
Terms of Reference of the Strategy Committee of the Board of Directors (401KB)
Release Time: 20/06/2025 12:15 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of the Nomination Committee]
Terms of Reference of the Nomination Committee of the Board of Directors (413KB)
Release Time: 20/06/2025 12:10 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of the Remuneration Committee]
Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors (412KB)
Release Time: 20/06/2025 12:04 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Terms of Reference of the Audit Committee]
Terms of Reference of the Audit Committee of the Board of Directors (423KB)
Release Time: 20/06/2025 12:00 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Constitutional Documents
Articles of Association (204KB)
Release Time: 13/06/2025 06:41 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Documents on Display
Documents on Display (Multi-Files)
Release Time: 13/06/2025 06:18 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Listing Documents - [Offer for Subscription]
GLOBAL OFFERING (24MB)
Release Time: 13/06/2025 06:08 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Announcements and Notices - [Formal Notice]
GLOBAL OFFERING (212KB)
Release Time: 09/06/2025 22:12 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Application Proofs, OC Announcements and Post Hearing Information Packs or PHIPs - [Post Hearing Information Packs or...
More
Application Proofs, OC Announcements and Post Hearing Information Packs or PHIPs - [Post Hearing Information Packs or PHIPs or related materials]
]
PHIP (1st submission) (Multi-Files)
Release Time: 09/06/2025 22:12 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Application Proofs, OC Announcements and Post Hearing Information Packs or PHIPs - [Post Hearing Information Packs or...
More
Application Proofs, OC Announcements and Post Hearing Information Packs or PHIPs - [Post Hearing Information Packs or PHIPs or related materials]
]
PHIP (1st submission) (12MB)
Release Time: 30/12/2024 22:52 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Application Proofs, OC Announcements and Post Hearing Information Packs or PHIPs - [OC Announcements or related materials]
OC Announcement - Appointment (46KB)
Release Time: 30/12/2024 22:48 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Application Proofs, OC Announcements and Post Hearing Information Packs or PHIPs - [Application Proofs or related materials]
Application Proof (1st submission) (11MB)
Release Time: 30/12/2024 22:48 Stock Code: 02617 Stock Short Name: TRANSTHERA-B Document:
Application Proofs, OC Announcements and Post Hearing Information Packs or PHIPs - [Application Proofs or related materials]
Application Proof (1st submission) (Multi-Files)
Showing 96 of 96 records
Showing 96 of 96 records
Disclaimer

Information contained in the materials available under the web page containing the hyperlink to this disclaimer is posted on this website for the purpose of providing information to the public in Hong Kong. It is not intended as investment advice and must not be relied on as such. It is the sole responsibility of any person who is located outside of Hong Kong to check and comply with all applicable laws and regulations before accessing and using the materials and information.

Please note that the web page contains materials and information provided to HKEX electronically (including information provided in electronic format) by listed issuers, new listing applicants and relevant parties and there is no agency, employee or partner relationship between HKEX and such parties. HKEX does not assume responsibility for screening, editing or monitoring such materials and the information contained in the materials. The information contained in the materials is not verified by HKEX.

HKEX and/or its subsidiaries take no responsibility for the materials and information available under the web page, make no representation as to their accuracy, reliability, completeness or ownership and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the information. Some materials may contain hyperlinks to external websites or web pages for which HKEX and/or its subsidiaries are not responsible. (Please see HKEX's "Hyperlink Policy").

Nothing herein shall constitute or be considered to be a limitation upon or a waiver of the privileges and immunities of HKEX and its subsidiaries, which are specifically reserved.

Copyright exists in the information and materials available under the web page and may belong to HKEX, to the author or to any other party depending on the circumstances of publications. Reproduction, distribution, use and/or linking without consent from the relevant parties is not permitted.

If you believe or are aware that any information contained in the materials is inaccurate, erroneous, unlawful, obscene, defamatory or infringes any intellectual property rights of a third party, please contact HKEX e-Submission by email at: ESSHotline@hkex.com.hk.